Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains reimbursement challenges that community settings face with access to multigene testing.
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains reimbursement challenges that community settings face with access to multigene testing.
Transcript
From a reimbursement standpoint, are there challenges with providing access to multigene testing in the community setting?
One of the problems with genetic testing is that many of the insurers have very rigorous policies about how they’ll allow testing, and that’s really restricted testing. In some cases even, large insurers have demanded that a genetic counselor do a consult. My own practice has been very fortunate to have genetic counselors for over 20 years, and they are wonderful, but they can be overwhelmed with the amount of patients. So, if we’re going to expand the criteria, then we have to have the insurance say we’re going to pay for this and we also have to have new delivery models of how people get tested and how they’re explained what the results of those testing are. One of the things about genetic testing that’s different than traditional taking care of patients is you’re not just talking about the person whose being tested because it has implications for the family. And so, you have to think more broadly of how are we going to get more people in to test, what is their decision making, how do we inform them on it, and there are issues there of expanded insurance.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More